These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 26993043)

  • 21. Skeletal muscle increases FGF21 expression in mitochondrial disorders to compensate for energy metabolic insufficiency by activating the mTOR-YY1-PGC1α pathway.
    Ji K; Zheng J; Lv J; Xu J; Ji X; Luo YB; Li W; Zhao Y; Yan C
    Free Radic Biol Med; 2015 Jul; 84():161-170. PubMed ID: 25843656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Minireview: Roles of Fibroblast Growth Factors 19 and 21 in Metabolic Regulation and Chronic Diseases.
    Zhang F; Yu L; Lin X; Cheng P; He L; Li X; Lu X; Tan Y; Yang H; Cai L; Zhang C
    Mol Endocrinol; 2015 Oct; 29(10):1400-13. PubMed ID: 26308386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibroblast growth factor-21, energy balance and obesity.
    Giralt M; Gavaldà-Navarro A; Villarroya F
    Mol Cell Endocrinol; 2015 Dec; 418 Pt 1():66-73. PubMed ID: 26415590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolism: Adiponectin---a mediator of specific metabolic actions of FGF21.
    Goetz R
    Nat Rev Endocrinol; 2013 Sep; 9(9):506-8. PubMed ID: 23856819
    [No Abstract]   [Full Text] [Related]  

  • 25. Fibroblast growth factor 21 reverses suppression of adiponectin expression via inhibiting endoplasmic reticulum stress in adipose tissue of obese mice.
    Guo Q; Xu L; Liu J; Li H; Sun H; Wu S; Zhou B
    Exp Biol Med (Maywood); 2017 Feb; 242(4):441-447. PubMed ID: 27811171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of fibroblast growth factor 21 action induces insulin resistance, pancreatic islet hyperplasia and dysfunction in mice.
    So WY; Cheng Q; Xu A; Lam KS; Leung PS
    Cell Death Dis; 2015 Mar; 6(3):e1707. PubMed ID: 25811804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A feed-forward regulatory loop in adipose tissue promotes signaling by the hepatokine FGF21.
    Han MS; Perry RJ; Camporez JP; Scherer PE; Shulman GI; Gao G; Davis RJ
    Genes Dev; 2021 Jan; 35(1-2):133-146. PubMed ID: 33334822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FGF21 controls hepatic lipid metabolism via sex-dependent interorgan crosstalk.
    Chaffin AT; Larson KR; Huang KP; Wu CT; Godoroja N; Fang Y; Jayakrishnan D; Soto Sauza KA; Sims LC; Mohajerani N; Goodson ML; Ryan KK
    JCI Insight; 2022 Oct; 7(19):. PubMed ID: 35998055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of energy balance by fibroblast growth factor 21.
    Cuevas-Ramos D; Aguilar-Salinas CA
    Horm Mol Biol Clin Investig; 2016 Jun; 30(1):. PubMed ID: 27318658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic actions of fibroblast growth factor 21.
    Cuevas-Ramos D; Aguilar-Salinas CA; Gómez-Pérez FJ
    Curr Opin Pediatr; 2012 Aug; 24(4):523-9. PubMed ID: 22732636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibroblast growth factor 21 is elevated in metabolically unhealthy obesity and affects lipid deposition, adipogenesis, and adipokine secretion of human abdominal subcutaneous adipocytes.
    Berti L; Irmler M; Zdichavsky M; Meile T; Böhm A; Stefan N; Fritsche A; Beckers J; Königsrainer A; Häring HU; de Angelis MH; Staiger H
    Mol Metab; 2015 Jul; 4(7):519-27. PubMed ID: 26137439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21.
    Iglesias P; Selgas R; Romero S; Díez JJ
    Eur J Endocrinol; 2012 Sep; 167(3):301-9. PubMed ID: 22740503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of fibroblast growth factor 21 (FGF21) on energy balance, glucose and lipid metabolism.
    Cuevas-Ramos D; Almeda-Valdes P; Aguilar-Salinas CA; Cuevas-Ramos G; Cuevas-Sosa AA; Gomez-Perez FJ
    Curr Diabetes Rev; 2009 Nov; 5(4):216-20. PubMed ID: 19531026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nutritional regulation of fibroblast growth factor 21: from macronutrients to bioactive dietary compounds.
    Pérez-Martí A; Sandoval V; Marrero PF; Haro D; Relat J
    Horm Mol Biol Clin Investig; 2016 Sep; 30(1):. PubMed ID: 27583468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exercise ameliorates the FGF21-adiponectin axis impairment in diet-induced obese mice.
    Yang W; Liu L; Wei Y; Fang C; Zhou F; Chen J; Han Q; Huang M; Tan X; Liu Q; Pan Q; Zhang L; Lei X; Li L
    Endocr Connect; 2019 May; 8(5):596-604. PubMed ID: 30978696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FGF21 attenuates pathological myocardial remodeling following myocardial infarction through the adiponectin-dependent mechanism.
    Joki Y; Ohashi K; Yuasa D; Shibata R; Ito M; Matsuo K; Kambara T; Uemura Y; Hayakawa S; Hiramatsu-Ito M; Kanemura N; Ogawa H; Daida H; Murohara T; Ouchi N
    Biochem Biophys Res Commun; 2015 Mar; 459(1):124-30. PubMed ID: 25712519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The moderate essential amino acid restriction entailed by low-protein vegan diets may promote vascular health by stimulating FGF21 secretion.
    McCarty MF
    Horm Mol Biol Clin Investig; 2016 Feb; 30(1):. PubMed ID: 26872317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of fibroblast growth factor 21 in atherosclerosis.
    Kokkinos J; Tang S; Rye KA; Ong KL
    Atherosclerosis; 2017 Feb; 257():259-265. PubMed ID: 28012645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FGF21 as a mediator of adaptive responses to stress and metabolic benefits of anti-diabetic drugs.
    Kim KH; Lee MS
    J Endocrinol; 2015 Jul; 226(1):R1-16. PubMed ID: 26116622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Naringenin prevents obesity, hepatic steatosis, and glucose intolerance in male mice independent of fibroblast growth factor 21.
    Assini JM; Mulvihill EE; Burke AC; Sutherland BG; Telford DE; Chhoker SS; Sawyez CG; Drangova M; Adams AC; Kharitonenkov A; Pin CL; Huff MW
    Endocrinology; 2015 Jun; 156(6):2087-102. PubMed ID: 25774553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.